Betaxolol Tablets — Class I drug recall D-0049-2024
Terminated recall by KVK-Tech, Inc., reported 2023-10-25, distributed nationwide. Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bott
| Recall number | D-0049-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | KVK-Tech, Inc., Newtown, PA, United States |
| Recall initiated | 2023-09-20 |
| Classified | 2023-10-18 |
| Reported by FDA | 2023-10-25 |
| Terminated | 2025-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 1,488 bottles |
| NDC | 10702-0013, 10702-0013-01, 10702-0014, 10702-0014-01 |
| Lot numbers | 17853A |
| Expiration dates | 2027-06-30 |
Product
Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10702-013-01.
Reason for recall
Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0049-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.